ConductScience.org, home

Paper280147

Relative potencies of anti-herpes compounds.

Collins P and 1 other. Ann N Y Acad Sci, 1977. Cited by 59 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Relative potencies of anti-herpes compounds. Papers, record 280147. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/280147

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Relative potencies of anti-herpes compounds.
PubMed
Journal
Ann N Y Acad Sci
PubMed
Year
1977
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
59
iCite
Relative citation ratio, by iCite
2.33
iCite
Revised in PubMed
2019-06-16
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Collins PP
2Bauer DJD J

Source PubMed

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antiviral AgentsMajor topic
HerpesviridaeMajor topic
Microbial Sensitivity Tests
Viral Plaque Assay
Virus Cultivation

Source PubMed

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 59 citations.

PMIDTitleJournalYearIn PapersSource
28,883,376In vitro Evaluation of Acyclovir/Chitosan Floating Systems.Materials (Basel)2010https://conductscience.org/library/papers/28883376PubMed
9,420,039Flow cytometric analysis of herpes simplex virus type 1 susceptibility to acyclovir, ganciclovir, and foscarnet.Antimicrob Agents Chemother1997https://conductscience.org/library/papers/9420039PubMed
7,192,534Inhibition of cellular alpha and virally induced deoxyribonucleic acid polymerases by the triphosphate of acyclovir.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/7192534PubMed
6,324,666Inhibition of cellular alpha DNA polymerase and herpes simplex virus-induced DNA polymerases by the triphosphate of BW759U.Antimicrob Agents Chemother1984https://conductscience.org/library/papers/6324666PubMed
6,284,470Trifluridine: a review of its antiviral activity and therapeutic use in the topical treatment of viral eye infections.Drugs1982https://conductscience.org/library/papers/6284470PubMed
6,275,127Acyclovir-resistant mutants of herpes simplex virus type 1 express altered DNA polymerase or reduced acyclovir phosphorylating activities.J Virol1981https://conductscience.org/library/papers/6275127PubMed
6,272,627Activity of trifluorothymidine against cytomegalovirus.Antimicrob Agents Chemother1981https://conductscience.org/library/papers/6272627PubMed
6,264,131Phosphorylation of acyclovir [9-(2-hydroxyethoxymethyl)guanine] in Epstein-Barr virus-infected lymphoblastoid cell lines.J Virol1981https://conductscience.org/library/papers/6264131PubMed
6,254,061Acyclovir inhibition of Epstein-Barr virus replication.Proc Natl Acad Sci U S A1980https://conductscience.org/library/papers/6254061PubMed
6,182,836Effect of combinations of acyclovir with vidarabine or its 5'-monophosphate on herpes simplex viruses in cell culture and in mice.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/6182836PubMed
3,631,945Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxy-methylbut-1-yl)guanine (BRL 39123) in cell culture.Antimicrob Agents Chemother1987https://conductscience.org/library/papers/3631945PubMed
3,010,836Plaque autoradiography assay for the detection and quantitation of thymidine kinase-deficient and thymidine kinase-altered mutants of herpes simplex virus in clinical isolates.Antimicrob Agents Chemother1985https://conductscience.org/library/papers/3010836PubMed
2,987,969Potentiation of antiherpetic activity of acyclovir by ribonucleotide reductase inhibition.Proc Natl Acad Sci U S A1985https://conductscience.org/library/papers/2987969PubMed
2,817,855Activities of two new antiviral agents against guinea pig lymphotropic herpesvirus infection in vitro.Antimicrob Agents Chemother1989https://conductscience.org/library/papers/2817855PubMed
2,544,857The stereoselective enzymatic synthesis of 9-beta-D-2'-deoxyribofuranosyl 1-deazapurine.Nucleic Acids Res1989https://conductscience.org/library/papers/2544857PubMed
2,536,930
2-Acetylpyridine 5-[(dimethylamino)thiocarbonyl]-thiocarbonohydrazone (A1110U), a potent inactivator of ribonucleotide reductases of herpes simplex and varicella-zoster viruses and a potentiator of acyclovir.
Proc Natl Acad Sci U S A1989https://conductscience.org/library/papers/2536930PubMed
1,765,135Antimicrobial and antiviral activity of xylosyl-methylthio-adenosine, a naturally occurring analogue of methylthio-adenosine from Doris verrucosa.Experientia1991https://conductscience.org/library/papers/1765135PubMed
232,189Inhibition of herpes simplex virus-induced DNA polymerase activity and viral DNA replication by 9-(2-hydroxyethoxymethyl)guanine and its triphosphate.J Virol1979https://conductscience.org/library/papers/232189PubMed
202,961Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine.Proc Natl Acad Sci U S A1977https://conductscience.org/library/papers/202961PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/280147

GET https://conductscience.org/api/papers/v1/280147/authors